Antiaging agents: pharmacological therapy targeted at preserving skeletal muscle size and function in aging adults.

Jeremy R Pearson, Jenna M Bartley, Arny A Ferrando, David D Church

Department of Geriatrics, Donald W. Reynolds Institute on Aging, Center for Translational Research in Aging and Longevity, University of Arkansas for Medical Sciences, Little Rock, AR.Department of Geriatrics, Donald W. Reynolds Institute on Aging, Center for Translational Research in Aging and Longevity, University of Arkansas for Medical Sciences, Little Rock, AR. · pubmed

Paper

Abstract

Aging population rates are significantly increasing and improved quality of life during aging is a top priority. The decline in skeletal muscle mass and strength is a major concern with aging, as it impairs the ability to perform activities of daily living and significantly diminishes quality of life. Effective strategies to counteract this decline are necessary for supporting longevity and enhancing quality of life in older adults.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that pharmacological therapies can help preserve skeletal muscle size and function in aging adults. This research is relevant as it addresses a significant aspect of aging—muscle decline—which impacts longevity and quality of life.

Author of this paper? Send a correction.